Pharma News

Digital destiny – PharmaTimes

Sustaining digital products across pharma organisations

In the world of global health and pharma, the development and launch of digital products have become commonplace.

These products, often serving as vital communication channels with customer groups, hold immense potential for enhancing engagement, improving customer experience and driving business growth.

There is a chronic pattern, however, within health and pharma organisations – a tendency to create, launch and, then, neglect these digital products. This neglect stems from a combination of shifting priorities, short-term mandates and a failure to recognise the evolving needs of customers.

Check out the rest of the feature here

Source link
#Digital #destiny #PharmaTimes

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *